A Fight for Fairness: Maud Sarda on building a more ethical economy with Label Emmaüs
Sarda: "This isn’t just about the survival of a business; it’s about justice and survival as a whole. We’re fighting for a fairer world where second-hand goods are valued and everyone has access to high-quality, sustainable options."
Related
Spotlight Interview: Keles' Laurent Van Lerberghe On Digital Health Investing
"The region between the UK, France, and Benelux is becoming something like a new Palo Alto. Everything is reachable within two and a half hours, creating a concentrated ecosystem of talent, capital, and market opportunities."
Spotlight Interview: Fly Ventures' Marie Brayer
"What's really exciting is seeing the emergence of academic entrepreneurship in France."
Spotlight Interview: ValueCo CEO Mariem Mhadhbi On Making ESG Count in Capital Markets
"The name reflects what we aim to do: create real financial and market value while leveraging the collective intelligence of investors to inspire meaningful change."
Spotlight Interview: CEA-Leti Director Jean-René Lèquepeys
"We are there to make research activities, and to transfer the results of research activities to industry. Our model is lab to fab."
Latest
🤖 La Machine #24: Inside FlexAI's Ambitions 🤖
Pigment launches AI agents; Aldebaran Robotics folds; Eurazeo bets on infrastructure.
FlexAI: Pioneering Universal AI Compute Infrastructure
Modern AI workloads were being forced to run on computing architectures designed decades ago. FlexAI wants to create a faster, more flexible system that enables rapid scaling.
🇫🇷 French Tech Wire: Oh, Good Grief! The Great Funding Famine Deepens
VC funding remains in freefall as French startups go hungry; MSInsight offers hope to the future of cancer detection; Yubo offers hope to companies that want to be profitable.
MSInsight : Paving the Path towards Precision Oncology
CEO and co-founder Arnaud Dr. Cutivet: “MSI cancer cells are present in 4% of cancers, especially colorectal, stomach, and endometrial cancers. Early detection, particularly in colorectal cancer, means we can use immunotherapy effectively, potentially saving lives.”